Eurozone profits stage a comeback

Profits at European companies have been upgraded as the wide economy continues to pick up.

While US profits melt away, forecasts in Europe are being upgraded rapidly. Indeed, European earnings per share (EPS) growth should eclipse America's this year for the first time since 2008, says Morgan Stanley, which is forecasting a 12% increase.

The European economy could exceed expectations this year. Economies have surprised on the upside, with Spain and Germany doing especially well, according to the latest batch of GDP data: German GDP accelerated from 0.1% to 0.7% in the fourth quarter. German manufacturing orders have jumped and eurozone retail sales are at an eight-year high. The slump in the oil prices should provide another tailwind.

The sinking euro Morgan Stanley expects a 11% fall in the trade-weighted index this year is boosting foreign sales. The European Central Bank's (ECB) quantitative-easing (QE) programme should continue to weigh on the currency, as well as lowering corporate debt costs. There is evidence that the credit freeze appears to be thawing, even before the ECB's QE arrives. Liquidity, moreover, always finds its way into stocks.

While the earnings outlook is brightening, valuations are still very reasonable, with European stocks around a third cheaper in cyclically adjusted price/earnings (Cape) terms than their US counterparts, according to Pictet Asset Management's Luca Paolini. Spain and Italy, for instance, are on Capes of 11 and 8.5 respectively; Greece, a bet for the very brave, costs just 3.4 times. European stocks, already at seven-year highs, look set to keep rising.

Recommended

How the Covid-19 vaccine crisis is putting the EU in danger
EU Economy

How the Covid-19 vaccine crisis is putting the EU in danger

The botched coronavirus vaccine campaign will cause long-term harm to the EU's economy, says Matthew Lynn.
4 Apr 2021
How the vaccine wars will harm us all
Global Economy

How the vaccine wars will harm us all

Grabbing and hoarding vaccine supplies, or even manufacturing one’s own, might seem to make sense for a state in an emergency. But the damage done to …
27 Mar 2021
The European Central Bank fumbles its way towards yield curve control
EU Economy

The European Central Bank fumbles its way towards yield curve control

The EU’s economic recovery is faltering, but its bond yields keep rising. That makes things tricky for the European Central Bank, says John Stepek. He…
12 Mar 2021
Vexing vaccine delays hit drug firms
Biotech stocks

Vexing vaccine delays hit drug firms

AstraZeneca and Pfizer are being attacked by the EU over what it claims are delays in delivering the Covid vaccine.
28 Jan 2021

Most Popular

Central banks are rushing to build digital currencies. What are they, and what do they mean for you?
Bitcoin

Central banks are rushing to build digital currencies. What are they, and what do they mean for you?

As bitcoin continues to soar in value, many of the world’s central banks are looking to emulate it by issuing their own digital currencies. But centra…
8 Apr 2021
House prices: from boom to even bigger boom
House prices

House prices: from boom to even bigger boom

UK house prices have risen to new to record highs, says Nicole Garcia Merida. Demand continues to outpace supply, but continued low interest rates, th…
9 Apr 2021
Nuclear power might never be popular – but now looks a good time to invest
Commodities

Nuclear power might never be popular – but now looks a good time to invest

Nuclear power gets a very bad press, but it is the ultimate renewable energy source. Interest in it is perking up again, says John Stepek. Which means…
9 Apr 2021